Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model.
Mayzlish-Gati E, Laufer D, Grivas CF, Shaknof J, Sananes A, Bier A, Ben-Harosh S, Belausov E, Johnson MD, Artuso E, Levi O, Genin O, Prandi C, Khalaila I, Pines M, Yarden RI, Kapulnik Y, Koltai H.
Mayzlish-Gati E, et al. Among authors: prandi c.
Cancer Biol Ther. 2015;16(11):1682-8. doi: 10.1080/15384047.2015.1070982. Epub 2015 Jul 20.
Cancer Biol Ther. 2015.
PMID: 26192476
Free PMC article.